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Summary. The objective of this study was to determine
whether gynecological and periodontal clinical
parameters and the immunohistochemical expression in
placental chorionic villi of the markers cyclooxygenase-
2 (COX-2), interleukin (IL)-1β, vascular endothelial
growth factor receptor 1 (VEGFR1), podoplanin, and
Heat Shock Protein (HSP70) are associated with preterm
birth (PB) and/or low birth weight (LBW) neonates. 
Material and methods: An observational case-
control study was performed in 130 puerperal women:
mothers of PB/LBW neonates (cases, n=65) and mothers
of full-term normal-weight neonates (controls, n=65).
Data were gathered from all participants on socio-
demographic, gynecological, and periodontal variables
and on placental immunohistochemical COX-2, IL-1β,
VEGFR1, podoplanin, and HSP70 expression. 
Results: Among the 42 women with mild/moderate
periodontitis or gingivitis, the studied periodontal
variables were significantly worse and the placental
COX-2 (p=0.043), HSP70 (p=0.001), IL-1β (p=0.001),
VEGFR1 (p=0.032), and podoplanin (p=0.058)
expressions were significantly higher in the cases than in
the controls. In comparison to the mothers without
periodontitis, only COX-2 (p=0.026) and VEGFR1
(p=0.005) expressions were significantly increased in
those with the disease. Increased COX-2 values were
detected in the women with a history of genitourinary
infection (p=0.036), premature rupture of membrane
(p=0.012), or drug treatment (p=0.050).
Conclusions: The etiology of preterm birth and/or
low birth weight is multifactorial and involves
consumption habits, social-health factors, and infectious
episodes. These adverse pregnancy outcomes were
associated with periodontitis and the increased placental
expression of IL-1β, COX-2, VEGFR1, and HSP70.
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Introduction
Pregnancy and parturition involve a complex
interaction between mother and fetus that is not fully
understood. Adverse pregnancy outcomes, such as
preterm birth (PB) and low birth weight (LBW), are the
main cause of late perinatal and neonatal morbidity and
mortality (McCormick, 1985). Almost two decades ago,
it was proposed that PB and LBW are associated with
maternal periodontal status and oral microbial burden
(Offenbacher et al., 1996, 1998). The pathogenesis of PB
is considered multi-factorial, involving multiple
mechanisms such as infection, uteroplacental ischemia,
Preterm birth and/or low birth weight 
are associated with periodontal disease 
and the increased placental immunohisto-
chemical expression of inflammatory markers
Elena Pozo1, Francisco Mesa2, Mohamed H. Ikram1, Alberto Puertas3, Laura Torrecillas-Martínez4, 
Inmaculada Ortega-Oller4, Antonio Magán-Fernández2, María Dolores Rodríguez-Martínez6, 
Miguel Padial-Molina4,5, Elena Sánchez-Fernández4, Pablo Galindo-Moreno4 and Francisco O’Valle6
1Private practice in periodontics, Granada, Spain, 2Periodontology Department, School of Dentistry, University of Granada, Spain,
3Department of Obstetrics and Gynecology, Virgen de las Nieves University Hospital, Granada, Spain, 4Oral Surgery Department,
School of Dentistry, University of Granada, Spain, 5Department of Periodontics and Oral Medicine, School of Dentistry, University of
Michigan, Ann Arbor, MI, USA and 6Pathology Department, School of Medicine IBIMER, CIBM, University of Granada, Granada,
Spain
Histol Histopathol (2016) 31: 231-237
http://www.hh.um.es
Offprint requests to: Prof. Francisco O’Valle, School of Medicine,





From Cell Biology to Tissue Engineering
hemorrhage, stress, and other immunologically-mediated
processes (Romero et al., 2006). The periodontitis-
associated dental biofilm is thought to serve as an
important source of oral bacteria and related virulence
factors disseminated via the blood stream to the
fetoplacental unit (Arce et al., 2009), where an elevation
in inflammatory cytokines and mediators is produced
directly by the bacteria and their pathogenic products
and indirectly through an increase in these levels at
gingival level in response to periodontal pathogens
(Bobetsis et al., 2006).
A recent systematic review reported a consistent
association between periodontitis and PB and/or LBW,
but data must be taken with reservation (Chambrone et
al., 2011). However, contradictory results were reported
by six meta-analyses on the association between
maternal periodontal disease and the risk of PB and/or
LBW (Khader and Ta'ani, 2005; Vergnes and Sixou,
2007; Polyzos et al., 2009, 2010; Fogacci et al., 2001;
Corbella et al., 2012). Some authors proposed that
periodontitis may not be causally related to negative
pregnancy outcomes and that both may result from the
same hyperinflammatory and/or environmental
influences on the mothers (Ferguson et al., 2007)
(Klebanoff and Searle, 2006). Mixed results have been
published by periodontal intervention studies designed to
explore the possible causal relationship between
maternal periodontal infection/inflammation and the risk
of PB and/or LBW delivery. Discrepant results have also
been published by randomized trials evaluating the effect
of periodontal treatment on the risk of preterm birth
(Boutin et al., 2013). A multicenter clinical trial that
enrolled 823 patients found no significant treatment
effect of periodontal disease on live PB/LBW rates or
fetal growth but a borderline significant effect on fetal
loss through spontaneous abortion and still birth
(Michalowicz et al., 2006).
The mechanisms of human preterm labor appear
inextricably linked to cytokine biosynthesis by
gestational tissues (Mitchell et al., 2012). Several causal
factors have been related to these pregnancy disorders.
Expressions of cytokines and inflammatory mediators,
growth factors and proteins related to vascularization,
and oxidative stress have been studied in maternal blood
(Sata et al., 2009; Sert et al., 2011) and oral cavity
(Konopka et al., 2004). However, there have been no
reports on placental levels of these molecules. 
Inflammatory cytokines have been associated with
preterm birth, low birth weight, and even intrauterine
growth restriction (Konopka et al., 2004). Interleukin
(IL)-1β, a pro-inflammatory cytokine, has been
implicated in various chronic diseases, including
periodontitis. IL-1β is able to activate chemotactic
cytokines, adhesion molecules, and osteoclastic bone
resorption (Kornman et al., 1997; Kornman and Duff,
2001; Moreira et al., 2005) and may influence the onset
of premature labor (Genc and Ford, 2010). Inflammatory
mediators such as cyclooxygenase-2 (COX-2) are also
involved in the induction of parturition, and COX-2
expression is known to increase in fetal membranes at
the onset of labor (Slater et al., 1999). 
The vascular endothelial growth factor (VEGF)
family comprises angiogenic factors essential for the
development of the placenta. It regulates angiogenesis,
the degradation of the extracellular matrix, and vascular
endothelium by stimulating VEGFR-1 and VEGFR-2
endothelial cell surface receptors (Suthin et al., 2003). 
Podoplanin is also related to angiogenesis.
Immunohistochemical studies have demonstrated the
presence of this sialoglycoprotein in placental stroma
cells during pregnancy, and a significant reduction in its
expression was recently reported in cases with adverse
outcomes (Wang et al., 2011). However, the role of this
protein and its function in the placenta remains
unknown.
Spontaneous mature birth and PB begin and proceed
in a similar manner. This is confirmed by the similar
involvement in both processes of corticotropin-releasing
hormone, urocortin, amniotic fluid extracellular stress
protein HSP70, prostaglandins, proinflammatory
cytokines or glucocorticosteroids (Pawelec et al., 2013).
There is an increase in oxidative stress during labor.
Heat shock proteins (HSPs), especially HSP90 and
HSP70, are activated to help cells recover from this type
of stress. HSP70, a cellular defense protein, is essential
for the normal function of cells under stress and acts as
an antiapoptotic protein to protect the fetus from this
stress during development of the placenta (Padmini et
al., 2012). 
The aim of this study was to determine the
association of PB and/or LWB with gynecological and
periodontal clinical variables and with the expression in
placental chorionic villi of the markers IL-1β, COX-2,
VEGFR1, podoplanin, and HSP70. 
Material and methods
An observational case/control study was conducted
in pregnant women hospitalized in Our Institution, who
were consecutively recruited between January 2013 and
December 2013. Inclusion criteria for cases were age ≥
18 years with PB (<37 weeks of gestation) and/or LBW
(<2.5 Kg) newborn. The control group included women
over 18 years old with full-term (≥35 weeks of
gestation) and normal-weight (>2.5 Kg) newborn.
Exclusion criteria for both cases and controls were: age
<18 years, presence of diabetes or systemic disease not
related to the pregnancy, a history of multiple
pregnancies, and interruption of the pregnancy for
medical reasons. After application of the study eligibility
criteria, the final study sample included 130 puerperal
women. The study was approved by the hospital ethics
committee. Written informed consent was obtained from
all study participants. 
Data on the mothers were gathered from their
clinical records, while information on the gestational age
and newborn weight values was obtained from the
Neonatology Department records. The periodontal health
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status of each woman was established by dental
examination. 
Socio-demographic and gynecological variables 
A single researcher (E.P.) interviewed the mothers
and looked for clinical records to gather socio-
demographic data on: age; ethnicity; marital status at the
delivery (married, single, separated, widow),
employment (yes/no); socioeconomic level, according to
the modified classification of J. Goldthorpe cited by
Regidor (2001), years of schooling; and consumption
during the pregnancy of tobacco (cigarettes/day), alcohol
(grams/day), and coffee (cups/day). Gynecological data
were collected on the number of previous pregnancies,
family history of PB/LBW, maternal weight before
pregnancy, weight gain during pregnancy, genitourinary
infections during pregnancy, and premature rupture of
membrane.
Periodontal variables
Variables were measured at a single time-point
during the 24 h after delivery (48-72 h after a cesarean
delivery). The periodontal examination was performed
in the hospital room, following World Health
Organization recommendations for oral examinations
and using a calibrated periodontal probe (University of
North Carolina No. 15 Probe, Hu-Friedy, Chicago, IL).
Periodontal status was assessed by determining: the
gingival bleeding index proposed by Ainamo and Bay
(1975); gingival recession for all teeth present, except
for third molars; and the probing depth (PD) and clinical
attachment (CA) loss at four sites per tooth (mesial,
distal, vestibular, and palatine/lingual). Periodontitis was
diagnosed when four or more teeth showed one or more
sites with PD ≥4 mm and CA loss ≥3 mm, based on the
definition by López et al. (2002) Patients who were not
diagnosed with periodontitis but showed bleeding on
probing were diagnosed with gingivitis.
Histopathological and immunohistochemical studies 
Placentas were assessed by a single pathologist
(F.O.), and samples were collected consistently from the
same paracentral placental region. Samples of
approximately 2x2 cm were obtained from all
participants, immediately fixed in 10% buffered formalin
for 48 h, and then embedded in paraffin. Tissue arrays
were prepared from punch biopsies of the paraffin
blocks using a disposable 4 mm punch (Kai Europe
GmbH, Solingen, Germany), and 4-µm sections were
dewaxed, hydrated, and stained using the hematoxylin-
eosin technique.
Tissue arrays of paraffin-embedded sections were
dewaxed, hydrated, and heat-treated in 1 mM EDTA pH
8 for antigenic unmasking in an antigen retrieval PT
module (Thermo Fisher Scientific Inc., Waltham, MA) at
95°C for 20 min. Sections were incubated for 10 min at
room temperature with prediluted monoclonal antibodies
against COX-2 (clone SP21) and podoplanin (clone: D2-
40), and polyclonal antibodies against HSP70, VEGFR1,
and IL-1β. All antibodies were purchased from Master
Diagnóstica, Granada, Spain. An appropriate isotype for
each antibody was used as negative control. 
The immunohistochemical study was conducted in
an automatic immunostainer (Autostainer 480,
LabVision Fremont, CA) using the micropolymer-
peroxidase-based method (Ultravision Quanto, Master
Diagnóstica, Granada, Spain), followed by development
with diaminobenzidine. A quantitative study of the
different immunostainings was done automatically using
ten black and white images per case of five independent
antibodies without hematoxylin staining. The algorithms
were implemented using specific analysis software
ImageJ v.1.46 (rsbweb.nih.gov/ij). Results were
expressed in terms of area (mm²) and grey levels
(integrated optic density [IOD]). 
Statistical analysis
A statistical software package (SPSS 20.0 IBM Inc.,
Chicago, IL) was used for the statistical analysis. The
normality of the distribution of variables was examined
with the one-dimensional Kolmogorov-Smirnov test.
The bivariate tests used are reported in the table
footnotes. Patients were stratified in four groups (PB and
full-term pregnant with or without LBW) for application
of the Kruskal-Wallis test. The general linear model was
applied with the group as dependent variables and the
immunohistochemical placental expression of markers
as independent variables. A p-value of 0.05 was accepted
as statistical significance threshold.
Results
This study included 130 puerperal women, 65
mothers with full-term normal-weight newborns
(controls) and 65 with PB/LBW (cases). In the control
group, the mean age was 29.4±4.4 yrs, mean gestation
period 39.6±1.1 weeks, and mean newborn weight
3.34±0.38 Kg. In the cases group, the mean age was
29.9±7.1 yrs, mean gestation 35.2±2.1 weeks, and mean
newborn weight 2.29±0.4 Kg; in this group, 10 children
had normal weight (≥2.5 Kg) but <37 weeks of
gestation, 10 children weighed <2.5 Kg but were full-
term deliveries, while 45 children weighed <2.5 Kg and
were preterm deliveries.
Table 1 compares socio-demographic and
gynecological data between cases and controls.
Significantly higher frequencies of a family history of
premature labor, genitourinary infections, hypertension
during pregnancy, and coffee consumption were found in
cases than in controls. Table 2 compares periodontal data
between groups, showing significantly worse values for
all variables in the cases group; 88 women had no
periodontal disease. Among the 42 women with
mild/moderate periodontitis or gingivitis, the studied
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periodontal variables were significantly worse in cases
than in controls. Chronic periodontitis was diagnosed in
11(16.41%) of the cases and 5 (7.81%) of the controls
(p<0.01 chi-square test with Yates correction).
Biopsies of placental cotyledons were obtained from
all cases (n=65) and controls (n=65). In all samples, the
morphological study evidenced: third-trimester chorionic
villi with appropriate vascular development; no
inflammatory phenomena or histopathological signs of
chronic villitis, chorioamnionitis, or placental
chorangiosis; a normal number of intravillous Hofbauer
cells; and no villous trophoblast abnormalities. COX-2
immunoreactivity was detected in amniotic epithelial
cells, chorion cells, and decidual cells (data not shown),
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Fig. 1. Morphological features of third-trimester chorionic villi with appropriate vascular development, with no histopathological signs of chronic villitis or
chorioamnionitis. A. Control group. B. Case group (Hematoxylin-eosin). x 20
Table 1. Socio-demographic and gynecological data of the pregnant
women (n=130).
Variable Controls Cases (PB/LBW)
(n=65) (n=65) P-value
Ethnicity (% Caucasian) 83.1 84.6 0.793‡
Marital status (% married) 69.2 52.3 <0.001‡
Employed (% yes) 53.8 55.4 0.337‡
Social level.(range, I-VII), median VI VII 0.219§
Schooling (yrs), mean±sd 11.5±4.8 10.2±4.1 0.106†
Nº previous pregnancies, mean±sd 1.36±1.10 1.45±1.69 0.725†
Family history of premature labor, %* 9.2 18.5 <0.001‡
Genitourinary infection, % 21.5 35.4 <0.001‡
Premature rupture of membrane, % 6.2 55.4 <0.001‡
Coffee (No-1 cup week -1 cup daily) 57-4-4 43-22-0 0.016§
Tobacco (Never/ex-smoker.- ≤10/day - >10/day) 49-3-4-9 32-15-5-13 0.793‡
Alcohol, % (None-≤ 5 g/day- >5 g/day 64-1-0 64-0-1 0.328§
Arterial hypertension during pregnancy,% 1.5 4.6 <0.001‡
*Data not gathered in 1 case and 2 controls; †Student’s t test; ‡chi-
square test with Yates correction; §Mann-Whitney U-test.
Table 2. Description and comparison of periodontal status of puerperal
women (n=130).
Variable Controls Cases (PB/LBW)
(n=65) (n=65) p-values
Gingival bleeding index*(%) 18.2±24.7 24.6±30.6 0.188‡
Gingival recession* (mm) 0.04±0.09 0.10±0.23 0.097‡
Depth of sulcus* (mm) 1.59±0.34 1.76±0.62 0.050‡
Clinical attachment loss* (mm) 1.64±0.38 1.86±0.81 0.049‡
Patients with periodontitis (%) 7.81 16.41 <0.01†
Nº sites measured* 109±6 108±7 0.378‡
*Values are expressed as mean ± standard deviation; †chi-square test
with Yates correction; ‡Student’s t test.
Table 3. Comparison of placental immunohistochemical expression of
different molecules between groups (n=126).‡
Variable Control Cases (PB/LBW) p-values†
Podoplanin# 1.05±0.92 1.56±1.09 0.058
IL-1β (mm2) 0.03±0.04 0.03±0.03 0.207
IL-1β* 4.49±7.30 6.48±6.10 0.001
COX-2 (mm2) 0.13±0.02 0.14±0.02 0.043
COX-2* 39.48±25.75 47.38±31.42 0.124
HSP70 (mm2) 0.03±0.03 0.03±0.03 0.219
HSP70* 4.53±7.61 6.69±6.91 0.001
VEGFR1 (mm2) 0.05±0.01 0.05±0.01 0.706
VEGFR1* 5.36±2.55 6.18±3.77 0.383
Values are expressed as mean±standard deviation; #Semi-quantitative
scale (0-3 points); *Optic density values (gray levels). †Mann-Whitney U-
test. ‡Four samples were non-assessable.
and strong COX-2 expression was observed in the
syncytiotrophoblast, which was increased in the
PTB/LBW cases. IL-1β, VEGFR1, and HSP70
expression was observed in trophoblastic cells and was
more evident on the apical surface of the
syncytiotrophoblast layer than in stromal or muscle cells
of the blood vessels or Hofbauer cells; podoplanin was
only expressed in villous stroma. Table 3 compares the
quantitative immunohistochemical expression of COX-
2, IL-1β, VEGFR1, podoplanin, and HSP70 in chorionic
villi between cases and controls. Significantly increased
placental expressions of COX-2 (p=0.043), HSP70
(p=0.001), IL-1β (p=0.001), VEGFR1 (p=0.032), and
podoplanin (p=0.058, Kruskal-Wallis test) were detected
in the cases versus controls when patients were stratified
in four groups. The linear regression was statistically
significant (R=0.264, p=0.034) when the model included
the areas of immunostaining for COX-2 (p=0.042),
HSP70 (p=0.042), and IL-1β (p=0.041).
A higher placental expression of COX-2 (p=0.026)
and VEGFR1 (p=0.005, Mann-Whitney U-test) was
found in the women with periodontitis than in those
without this disease. Increased COX-2 values were
detected in the women with a history of genitourinary
infection during pregnancy (p=0.036), premature
membrane rupture (p=0.012), or drug treatment
(p=0.050, Mann-Whitney U-test).
Discussion
In this study of 130 puerperal women, PB and LBW
were associated with fewer schooling years, a heavier
smoking habit, and a higher frequency of genitourinary
infections and hypertension during pregnancy. Various
authors have reported the influence of these factors on
pregnancy outcomes. Kitsantas and Christopher (2013)
found a relationship between tobacco and PB/LBW in
their study of more than a million mothers. In addition,
infections have emerged as confounding variables in the
few published analyses of their role in the pathogenesis
of adverse pregnancy outcomes (Nigro et al., 2011). A
finding of particular interest in the present investigation
was the association found between PB/LBW and the
elevation of placental inflammatory markers.
The incidence of periodontitis was low in this series
of puerperal women, but it was higher in the mothers
with PB or LBW than in the controls. All periodontal
disease indicators examined were higher in the cases,
who evidenced more sites with bleeding on probing,
greater gingival recession, and worse PD and CAL
values. As noted by Manau et al. (2008) the significance
of the association between periodontal disease and
pregnancy outcomes can be influenced by the definition
of periodontal disease employed. We adopted the most
demanding definition of periodontitis, proposed by
Lopez et al. (2002) which requires the presence of four
or more teeth showing one or more sites with PD of ≥4
mm and CAL of ≥3 mm (at the same site). The
application of less strict criteria, as well as differences in
ethnic background and age among the study populations,
may explain the approximately three-fold higher
prevalence of periodontitis reported by Hasegawa-
Nakamura et al. (2001) (39.13%) and Tateishi et al.
(2012) (37.5%) in comparison to our finding of 12.21%. 
Placental morphology findings were similar between
the groups and compatible with disease-free third-
trimester chorionic villi. However, the cases and controls
differed in the immunohistochemical expression of pro-
inflammatory, vasculogenic, and oxidative stress
markers in the placenta. 
The increased expression of IL-1β and COX-2 in
placental trophoblasts from the cases suggests that a
subclinical protoinflammatory state at the maternal-fetal
interface may have contributed, among other factors, to
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Fig. 2. Representative immunohistochemical expression of different markers in placentas. The cases showed increased expression versus the controls.
Note that COX-2 and podoplanin are counterstained with hematoxylin, while the microphotographs for IL-1β, VEGFR1, and HSP70 are without
counterstaining because they were taken for image analysis study. (Micropolymer peroxidase-based method). x 10
triggering preterm delivery. This supports the
proposition that the regulation of COX-2 in placental
membranes may mediate an increase in prostaglandin
synthesis, which promotes parturition. It therefore
appears reasonable to conclude that the elevated COX-2
and IL-1β levels produced by a pro-inflammatory state
in the mother may have a negative effect on the
pregnancy outcome. Similar findings were reported in a
previous study by our group (Mesa et al., 2013),
although the higher expression of COX-2 was not
significant, possibly because it was assessed in a semi-
quantitative manner, unlike in the present quantitative
study, in which statistical significance was reached. 
Recent studies have linked the VEGF family and its
receptors to adverse pregnancy outcomes. Some authors
have implicated decreased placental levels of this family
of angiogenic growth factors in the pathogenesis of
preterm birth (Andraweera et al., 2012), and an increase
in these levels has been reported to indicate a response to
hypoxia or ischemia (Kumazaki et al., 2002). Serum
levels of VEGF and VEGFR-1 and 2 may also be
associated with periodontal disease through an increase
in vascular permeability and angiogenesis (Sert et al.,
2011; Horton and Boggess, 2012). 
The placental expression of podoplanin has been
related to fetal angiogenesis during placenta
development, and a reduced podoplanin level was
recently detected in preeclamptic placentas (Pawelec et
al., 2013). In the present study, the expression of
podoplanin in placental stromal cells was higher in the
PB/LBW cases than in the controls, and this higher
expression might have contributed to the adverse
pregnancy outcomes. However, the role of this protein in
the placenta has yet to be elucidated.
Extracellular HSP70 is known to be involved in
activation of the innate and adaptive immune response,
and increased serum HSP70 levels appear to reflect
systemic inflammation and oxidative stress (Molvarec et
al., 2009). High placental HSP levels were reported to
indicate hypoxic or ischemic changes and the struggle of
cells to survive (Padmini et al., 2012). This enhanced
expression probably represents a protective response to
cellular stress. Intra-amniotic infection, histologic
chorioamnionitis, and delivery have been associated
with elevated amniotic fluid HSP70 concentrations
(Chaiworapongsa et al., 2008). HSP70 plays a role in the
host defense mechanism by activating the innate arm of
the immune response in women with intrauterine
infection, and extracellular HSP70 may be involved in
the mechanisms of preterm and term parturition
(Chaiworapongsa et al., 2008). In our study, increased
HSP70 expression in trophoblastic cells was related to
preterm parturition.
In conclusion, the etiology of preterm birth and/or
low birth weight is multifactorial and involves
consumption habits, social-health factors, and infectious
episodes. These adverse pregnancy outcomes are
associated with periodontitis and the increased placental
expression of IL-1β, COX-2, VEGFR1, and HSP70.
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